BioNexus Gene Lab appoints Dr. Muthu Meyyappan as CCO of Fidelion
Go back to BioNexus Gene Lab appoints Dr. Muthu Meyyappan as CCO of Fidelion| (NASDAQ: BGLC) | Delayed: 1.57 +0.03 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.54 | 52 Week High | $ | |||
| Open | $1.57 | 52 Week Low | $ | |||
| Day High | $1.66 | P/E | N/A | |||
| Day Low | $1.57 | EPS | $ | |||
| Volume | 8,699 | |||||
